Can-Fite BioPharma Ltd. (TLV:CANF)
Israel · Delayed Price · Currency is ILS · Price in ILA 682.90
-38.10 (-5.28%)
Jan 9, 2026, 1:44 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 17.88 million as of January 9, 2026. Its market cap has decreased by -68.76% in one year.
Market Cap
17.88M
Enterprise Value
-3.57M
Revenue
1.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
682.90
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from 69.53M to 17.88M, a decrease of -74.28%. That is a compound annual growth rate of -7.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 17.88M | -77.24% |
| Dec 31, 2025 | 78.55M | 38.59% |
| Dec 31, 2024 | 56.68M | 77.98% |
| Dec 31, 2023 | 31.85M | -53.53% |
| Dec 29, 2022 | 68.52M | -42.86% |
| Dec 30, 2021 | 119.91M | 29.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 118.47B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.47B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 653.41M |